Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-01 @ 4:53 AM
Study NCT ID:
NCT00368056
Status:
COMPLETED
Last Update Posted:
2012-02-22
First Post:
2006-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2006-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-23
First Submit QC Date:
None
Study First Post Date:
2006-08-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-21
Last Update Post Date:
2012-02-22
Last Update Post Date Type:
ESTIMATED